Sanofi, Watson Resolve Patent Dispute Over Plavix
Sanofi-Aventis has reached a deal with Watson Pharmaceuticals Inc. in a long-standing patent infringement suit over Watson's attempt to market a generic version of the blockbuster blood thinner Plavix....To view the full article, register now.
Already a subscriber? Click here to view full article